Juliette is one of just 33 children in the world taking a new injectable drug to keep her rare blood disease from attacking ...

The complement system consists of a cascade of linked proteins that are activated in response to infection or tissue damage.

The Complement group, headed by Prof. Seppo Meri, has for long had an interest in sorting out how and why the complement system contributes to disease pathogenesis, how the system is controlled and ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced interim results from a Phase 1/2a clinical study of ARO-CFB, the company’s investigatio ...

Camilla Chong, MD, Chief Medical Officer of InflaRx, commented: "We are pleased to have started our Phase 2a trial for INF904 ...